些业期现日报 投资咨询业务资格:证监许可【2011】1292号 2025年6月25日 要指示 Z0019144 苯乙烯上游 | 品种 | 6月24日 | 6月23日 | 涨跌 | 涨跌幅 | 单位 | | --- | --- | --- | --- | --- | --- | | Brent原油(8月) | 67.1 | 71.5 | -4.3 | -6.1% | 美元/桶 | | CFR日本石脑油 | 586.0 | 642.0 | -56.0 | -8.7% | | | CFR东北亚乙烯 | 850.0 | 850.0 | 0.0 | 0.0% | | | CFR韩国纪本 | 733.0 | 773.0 | -40.0 | -5.2% | 美元/吨 | | CFR中国纯苯 | 747.0 | 791.0 | -44.0 | -5.6% | | | 纯苯-石脑油 | 161.0 | 149.0 | 12.0 | 8.1% | | | 乙烯-石脑油 | 264.0 | 208.0 | 56.0 | 26.9% | | | 纯苯华东现货价 | 6045.0 | 6400.0 | -355.0 | -5.5% | ...

Core Viewpoint - CF Industries (CF) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Performance - The Zacks rating system is based on changes in a company's earnings picture, with the Zacks Consensus Estimate reflecting EPS estimates from sell-side analysts [1][2]. - The correlation between earnings estimate revisions and stock price movements is strong, with institutional investors using these estimates to determine fair value [4][6]. - For CF, the recent increase in earnings estimates suggests an improvement in the company's underlying business, likely leading to higher stock prices [5][10]. Earnings Estimate Revisions for CF - CF is projected to earn $6.82 per share for the fiscal year ending December 2025, showing no year-over-year change [8]. - Over the past three months, the Zacks Consensus Estimate for CF has increased by 10%, indicating a positive trend in earnings expectations [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 (Strong Buy) stocks historically generating an average annual return of +25% since 1988 [7]. - The upgrade of CF to a Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, suggesting a strong potential for market-beating returns in the near term [9][10].

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades. Eve ...

【市场回顾】 大宗商品研究 能源化工研发报告 尿素日报 2025 年 6 月 24 日 尿素日报 1、期货市场：尿素期货宽幅震荡，最终报收 1698（-16/-0.93%）。 2、现货市场：出厂价延续跌势，成交乏力，河南出厂报 1710-1730 元/吨，山东小 颗粒出厂报 1700-1780 元/吨，河北小颗粒出厂 1740-1750 元/吨，山西中小颗粒出厂报 1620-1680 元/吨，安徽小颗粒出厂报 1730-1740 元/吨，内蒙出厂报 1620-1690 元/吨。 【重要资讯】 【尿素】6 月 24 日，尿素行业日产 19.86 万吨，较上一工作日减少 0.12 万吨，较去 年同期增加 2.91 万吨；今日开工 85.79%，较去年同期 78.27%回升 7.52%。 【逻辑分析】 今日，市场情绪依旧低迷，主流地区尿素现货出厂报价跌幅扩大，成交乏力。山东 地区主流出厂报价大幅领跌，市场情绪表现一般，工业复合肥开工率降至低位，原料库 存充裕，成品库存偏高，基层订单稀少，刚需补货为主，农业继续刚需采购，贸易商出 货为主，新单成交一般，待发消耗，预计出厂报价继续下跌为主；河南地区市场情绪低 迷，出厂报 ...

近期，亚钾国际动态频繁。6月20日，公司董事会审议通过召开2025年第二次临时股东大会的议案，计 划于7月7日讨论修订公司章程事项。此外，公司近日获得老挝总理府颁发的《亚钾工业园区政令》，为 园区非钾产业项目提供税收、土地等优惠政策，进一步拓展盈利空间。 此前，6月16日市场消息显示，2025年钾肥进口合同价同比上涨27%，推动亚钾国际股价创2022年9月以 来新高。公司还在6月13日披露老挝钾肥项目进展，称将动态调整销售策略并推进后续产能扩建。截至 2025年一季度，亚钾国际营业收入12.13亿元，归母净利润3.84亿元。 来源:金融界 2025年6月24日，亚钾国际（000893）发生一笔大宗交易，成交77万股，金额2289.98万元，成交价29.74 元/股，较当日收盘价30.33元折价1.95%。买卖双方均为海通证券股份有限公司贵阳长岭北路证券营业 部。该笔交易占当日竞价交易成交额3.59亿元的6.37%。 当日，亚钾国际股价上涨1.98%，开盘报29.86元，最高触及30.77元，成交额3.59亿元，总市值达280.26 亿元。公司所属化肥行业、广东板块等概念近期表现活跃，动态市盈率为18.23。 ...

Group 1 - The core viewpoint of the article highlights the performance and valuation of Yara International, noting its stock price increase and market capitalization [1] - As of June 24, Yara International's closing price was 30.33 yuan, with a PE ratio of 22.35 times, and a total market value of 28.026 billion yuan [1] - The average PE ratio in the fertilizer industry is 24.69 times, with a median of 22.52 times, placing Yara International at the 15th position in the industry ranking [1] Group 2 - As of the first quarter of 2025, 34 institutions held shares in Yara International, including 25 funds, 8 other entities, and 1 social security fund, with a total holding of 445.682 million shares valued at 10.884 billion yuan [1] - Yara International's main business includes potassium salt mining, potassium fertilizer production, and sales, with key products being potassium chloride, brine, and others [1] - The latest financial results for the first quarter of 2025 show that the company achieved an operating income of 1.213 billion yuan, a year-on-year increase of 91.47%, and a net profit of 384 million yuan, a year-on-year increase of 373.53%, with a gross profit margin of 54.12% [1]

Core Viewpoint - The company plans to invest in a new specialized fertilizer project in collaboration with the government of Huai Shang District, with a total investment of 1.15 billion RMB [1] Group 1: Project Details - The project involves the construction of a 1 million tons/year specialized crop fertilizer facility, which includes 400,000 tons/year of high tower compound fertilizer, 400,000 tons/year of urea-based compound fertilizer, 150,000 tons/year of soil testing formula BB fertilizer, and 50,000 tons/year of high-end water-soluble fertilizer [1] - The total investment for the project is 1.15 billion RMB, with fixed asset investment estimated at 980 million RMB [1] - The construction period is approximately 12 months, with an expected start date before December 31, 2025, and completion by December 31, 2026 [1] Group 2: Land and Approvals - The project will occupy an area of approximately 322 acres, with about 266 acres designated for chemical use [1] - The implementation of the project is subject to various pre-approval procedures, including government project approval, environmental impact assessment, and construction permits, which introduces uncertainty [1]

尿素日报 | 2025-06-24 地缘影响减弱，尿素震荡走低 市场分析 价格与基差：2025-06-23，尿素主力收盘1711元/吨（-19）；河南小颗粒出厂价报价：1760 元/吨（0）；山东地区小 颗粒报价：1750元/吨（-70）；江苏地区小颗粒报价：1770元/吨（-60）；小块无烟煤750元/吨（+0），山东基差：39 元/吨（-51）；河南基差：49元/吨（-41）；江苏基差：59元/吨（-41）；尿素生产利润220元/吨（-70），出口利润648 元/吨（+136）。 供应端：截至2025-06-23，企业产能利用率88.28%（0.08%）。样本企业总库存量为113.60 万吨（-4.11），港口样本 库存量为29.50 万吨（+5.00）。 需求端：截至2025-06-23，复合肥产能利用率31.82%（-1.99%）；三聚氰胺产能利用率为64.32%（+0.55%）；尿素 企业预收订单天数6.29日（+0.58）。 伊朗以色列地缘对尿素盘面影响减弱，重回基本面交易，尿素震荡走低。尿素开工高位运行，装置检修计划偏少， 产量预计走高，供应端压力较大。尿素下游农业需求追肥补货需求释放，工厂预售 ...

聚酯产业链日报 投资咨询业务资格:证监许可 【2011】1292号 张晓珍 Z0003135 | 下游聚酯产品价格及现金流 | 上游价格 | 品种 | 6月20日 | 张跌 | 单位 | 品种 | 6月20日 | 6月23日 | 6月23日 | 胀跌 | 单位 | 张跌幅 | 旅跌幅 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | -7.2% | 77.01 | -5.53 | POY150/48价格 | 60 | 布伦特原油(8月) | 71.48 | 7225 | 7165 | 0.8% | 美元/桶 | -7.2% | 50 | WTI原油(8月) | 68.51 | 73.84 | -5.33 | FDY150/96价格 | 7515 | 0.7% | 7465 | | | 40 | CFR日本石脑油 | 646 | -4 | -0.6% | D ...

Group 1: Industry Overview - The petroleum and chemical indices primarily experienced declines last week, with the chemical raw materials index down by 1.16% and the chemical pharmaceutical index down by 5.37% [1] - The international crude oil prices showed high volatility due to the conflict between Israel and Iran, with WTI crude oil futures settling at $74.93 per barrel, up 2.67%, and Brent crude oil futures at $77.01 per barrel, up 3.75% as of June 20 [1] Group 2: Chemical Products Performance - The top five rising petrochemical products included p-xylene up by 10.53%, aniline up by 6.53%, purified terephthalic acid up by 6.01%, butyl acrylate up by 5.19%, and C9 fraction up by 4.96% [1] - The top five declining petrochemical products included liquid chlorine down by 60%, vitamin D3 down by 8.57%, acrylic short fiber down by 7.89%, vitamin E down by 6.25%, and methyl acrylate down by 5.88% [1] Group 3: Capital Market Performance - The top five rising listed chemical companies in the Shanghai and Shenzhen markets included Tongyuan Petroleum up by 42.09%, Zhun Oil Co. up by 40.23%, Jinniu Chemical up by 27.43%, Maohua Shihua up by 22.67%, and Honghe Technology up by 22.58% [2] - The top five declining listed chemical companies included ST Haiyue down by 38.85%, Aoyang Health down by 26.33%, Huaye Fragrance down by 20.41%, Jiangtian Chemical down by 19.22%, and Shanshui Technology down by 18.77% [2]